117 related articles for article (PubMed ID: 21921346)
1. Detecting bone marrow metastasis in cerebellar medulloblastoma: value of disease surveillance with FDG-PET in this setting.
Basu S; Gupta T; Jalali R; Shet T
Indian J Cancer; 2011; 48(3):373-4. PubMed ID: 21921346
[No Abstract] [Full Text] [Related]
2. Demonstration of diffuse leptomeningeal metastasis in a treated case of medulloblastoma with F-18 FDG PET/CT.
Tripathi M; Jain N; Jaimini A; Garg G; D'souza MM; Sharma R; Grover RK; Mondal A
Clin Nucl Med; 2009 Aug; 34(8):530-2. PubMed ID: 19617737
[No Abstract] [Full Text] [Related]
3. Metastatic Medulloblastoma: 18F-FDG and 68Ga-DOTANOC PET/CT in Response Evaluation.
ArunRaj ST; Kumar A; Kp H; Mohan N; Gupta S; Tripathi M; Bal C
Clin Nucl Med; 2021 May; 46(5):e262-e263. PubMed ID: 33315670
[TBL] [Abstract][Full Text] [Related]
4. Extracranial recurrence in the bone marrow of adult medulloblastoma patient - a therapeutic trap.
Rogowski W; Wachula E
J BUON; 2015; 20(1):352. PubMed ID: 25778341
[No Abstract] [Full Text] [Related]
5. Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma.
Aydin A; Yu JQ; Zhuang H; Alavi A
Clin Nucl Med; 2005 Sep; 30(9):606-7. PubMed ID: 16100478
[TBL] [Abstract][Full Text] [Related]
6. Submandibular gland carcinoma with unusual widespread bone marrow metastases detected by Tc-99m MDP bone scan and FDG PET.
Ko HL; Tsang YW; Chen YK; Chi KH
Clin Nucl Med; 2007 Nov; 32(11):866-7. PubMed ID: 18075424
[No Abstract] [Full Text] [Related]
7. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
8. Early bone marrow metastasis detection: the additional value of FDG-PET/CT vs. CT imaging.
Evangelista L; Panunzio A; Polverosi R; Ferretti A; Chondrogiannis S; Pomerri F; Rubello D; Muzzio PC
Biomed Pharmacother; 2012 Sep; 66(6):448-53. PubMed ID: 22902054
[TBL] [Abstract][Full Text] [Related]
9. A rare case of bone marrow infiltration by medulloblastoma in a child.
Santarsieri A; Dickens E; Hook CE; Allinson K; Matys T; Murray MJ
Br J Haematol; 2019 Jun; 185(6):1015. PubMed ID: 31172519
[No Abstract] [Full Text] [Related]
10. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
11. Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan.
Hong J; Lee JH
Ann Hematol; 2013 Apr; 92(4):565-6. PubMed ID: 23086509
[No Abstract] [Full Text] [Related]
12. Bone marrow metastases from alveolar rhabdomyosarcoma with impressive FDG PET/CT finding but less-revealing bone scintigraphy.
Yang J; Zhen L; Zhuang H
Clin Nucl Med; 2013 Dec; 38(12):988-91. PubMed ID: 24152640
[TBL] [Abstract][Full Text] [Related]
13. Using a cut-off SUV level to define bone marrow lesions on FDG PET is not appropriate.
Cheng G
Ann Hematol; 2013 Jan; 92(2):283-4. PubMed ID: 22885991
[No Abstract] [Full Text] [Related]
14. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
Purz S; Mauz-Körholz C; Körholz D; Hasenclever D; Krausse A; Sorge I; Ruschke K; Stiefel M; Amthauer H; Schober O; Kranert WT; Weber WA; Haberkorn U; Hundsdörfer P; Ehlert K; Becker M; Rössler J; Kulozik AE; Sabri O; Kluge R
J Clin Oncol; 2011 Sep; 29(26):3523-8. PubMed ID: 21825262
[TBL] [Abstract][Full Text] [Related]
15. PET/CT findings for bone marrow carcinosis because of lung adenocarcinoma.
Watanabe K; Shinkai M; Nagai K; Yamaguchi N; Ishigatsubo Y; Kaneko T
J Thorac Oncol; 2013 Nov; 8(11):1456-7. PubMed ID: 24128717
[No Abstract] [Full Text] [Related]
16. FDG-PET/CT Demonstrates Splenic Angiosarcoma Bone Marrow Metastasis.
Takahashi H; Hara T; Suzuki H; Hashimoto R; Minami M
Clin Nucl Med; 2020 Jan; 45(1):e20-e23. PubMed ID: 31306197
[TBL] [Abstract][Full Text] [Related]
17. [Conspicuous MRI image of the spine after treatment of a medulloblastoma. Diffuse bone marrow metastasis of medulloblastoma].
Deinzer M; Walter K; Reiche W; Glöbel H; Voges M; Struffert T; Reith W
Radiologe; 2001 Jul; 41(7):595-7. PubMed ID: 11490782
[No Abstract] [Full Text] [Related]
18. FDG PET in epithelioid hemangioendothelioma.
Rest CC; Botton E; Robinet G; Conan-Charlet V; Bizais Y; Visvikis D
Clin Nucl Med; 2004 Dec; 29(12):789-92. PubMed ID: 15545879
[TBL] [Abstract][Full Text] [Related]
19. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes.
Inoue K; Okada K; Harigae H; Taki Y; Goto R; Kinomura S; Kato S; Kaneta T; Fukuda H
Clin Nucl Med; 2006 Nov; 31(11):721-3. PubMed ID: 17053396
[TBL] [Abstract][Full Text] [Related]
20. Extraneural metastases in medulloblastoma.
Muoio VM; Shinjo SO; Matushita H; Rosemberg S; Teixeira MJ; Marie SK
Arq Neuropsiquiatr; 2011; 69(2B):328-31. PubMed ID: 21625760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
